FDA Inspection
Gland Pharma LimitedGland Pharma Limited – FDA Inspection, May 16, 2019
Record Details
This FDA Inspection record concerns Gland Pharma Limited, with an inspection on May 16, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 826a0fc9-eaf4-4d9e-9236-b51098beb6ed
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1090548
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
7- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.67(b)(2)Cleaning SOPs/schedules
- 21 CFR 211.42(b)Product flow through building is inadequate
- 21 CFR 211.56(c)Written procedures lacking for use of pesticides etc.
- 21 CFR 211.67(b)Written procedures fail to include
- 21 CFR 211.192Written record of investigation incomplete
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Gland Pharma Limited
7| Date | Classification | Office | Project area |
|---|---|---|---|
| July 25, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 14, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 25, 2022 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
| February 3, 2017 | VAI | Center for Drug Evaluation and Research | Generic Drug Evaluation |
| March 17, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Gland Pharma Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.